Fulminant Hepatic Failure

Fulminant Hepatic Failure is a topic covered in the Washington Manual of Medical Therapeutics.

To view the entire topic, please or .

The Washington Manual of Medical Therapeutics helps you diagnose and treat hundreds of medical conditions. Consult clinical recommendations from a resource that has been trusted on the wards for 50+ years. Explore these free sample topics:

-- The first section of this topic is shown below --

General Principles

  • FHF is a condition that includes evidence of a combination of coagulation abnormalities and any degree of mental alteration (encephalopathy) in a patient without preexisting liver disease and with an illness of <26 weeks in duration.
  • In 20% of cases, no clear cause is identified. Acetaminophen hepatotoxicity and viral hepatitis are the most common causes of FHF. Other causes include AIH, drug and toxin exposure, ischemia, acute fatty liver of pregnancy, WD, and Budd-Chiari syndrome.
  • Acute inflammation with varying degrees of necrosis and collapse of the liver’s architectural framework are the typical histologic changes seen in FHF.

-- To view the remaining sections of this topic, please or --

General Principles

  • FHF is a condition that includes evidence of a combination of coagulation abnormalities and any degree of mental alteration (encephalopathy) in a patient without preexisting liver disease and with an illness of <26 weeks in duration.
  • In 20% of cases, no clear cause is identified. Acetaminophen hepatotoxicity and viral hepatitis are the most common causes of FHF. Other causes include AIH, drug and toxin exposure, ischemia, acute fatty liver of pregnancy, WD, and Budd-Chiari syndrome.
  • Acute inflammation with varying degrees of necrosis and collapse of the liver’s architectural framework are the typical histologic changes seen in FHF.

There's more to see -- the rest of this entry is available only to subscribers.